文章結論

Conclusions：

Current mRNA vaccines are not reliably protecting individuals from infection or infection transmission. The rate of occurrence of adverse effects and the wide range of the types of adverse effects reported to date demonstrate the need for a better understanding of the benefits and risks of mass vaccination. Military readiness should be protected with early detection and diagnosis, plus early treatment and prophylaxis with a combination of safe repurposed drugs and immunologic support, rather than mandated use of incompletely tested novel products with potential serious adverse effects.